Saline tonometry has been replaced by automated air tonometry (TONOCAP®). As with saline tonometry there are some pitfalls to consider. We investigated the influence of different filling handicaps to the tonometry catheter sampling balloon on measurement of regional PCO 2 (PrCO 2 ). In an in vitro set-up, PrCO 2 was measured using the TONOCAP ® at intervals of 10 minutes from a 8F tonometry catheter sampling balloon placed in a container with constant PCO 2 (PcCO 2 ). Catheter alarms displayed by the TONOCAP® device were noted. The following experiments were performed: A) control measurement without modifications; B) adding deadspace of 7 ml into the sampling line; C) placing the sampling balloon in a 3 ml syringe; D) cross-clamping of the sampling balloon. Each experiment was performed four times using two catheters on two TONOCAP® devices. Differences between PcCO 2 and PrCO 2 were calculated as Pc-rCO 2 . Results are presented as mean±SD and were compared using ANOVA with Scheffe's correction. Pc-rCO 2 in the control set-up (A) amounted to 0.16±0.22%. Increasing catheter deadspace (B) resulted in a higher Pc-rCO 2 of 3.2±0.57% (P<0.0001). Restriction of balloon expansion (C) caused an Pc-rCO 2 gap of 1.17±0.36% (P<0.0001). With filling restriction (D) the Pc-rCO 2 gap increased to 3.87±0.29% (P<0.0001). The catheter alarms provided were not able to indicate all catheter problems and initial alarms disappeared although the problems continued. We conclude that impaired catheter deadspace to balloon volume relation can negatively influence accuracy of PrCO 2 measurement by the TONOCAP®.
Intestinal tonometry and, in particular, measurement of regional luminal partial pressure of carbon dioxide (PrCO 2 ) is a promising clinically available method for monitoring splanchnic perfusion 1, 2 .
Originally, PrCO 2 was measured from saline, instilled and aspirated through a standard nasogastric tube inserted in the stomach. In the 1980s, Fiddian-Green developed a tonometry catheter, a modified nasogastric tube with a sampling balloon on the distal end permeable to carbon dioxide 3 . The tonometry catheter was used with saline solution over two decades in more than 100 clinical studies 4 .
The introduction of automated air tonometry using the TONOCAP® device (Tonometrics, Helsinki, Finland) has markedly facilitated the assessment of PrCO 2 in the clinical setting 5, 6 . Air is pumped into the tonometer balloon, equilibrated and then aspirated for determination of partial pressure of CO 2 using an infrared analyser. To avoid depletion of luminal CO 2 and to reduce equilibration times, the gas mixture aspirated is re-pumped into the sampling balloon. Measurements are automatically performed at intervals of ten minutes or more by the TONOCAP® device. Air tonometry has been validated in vitro and in vivo by various investigators [7] [8] [9] [10] .
As with saline tonometry, there are some pitfalls to consider with air tonometry. As previously reported, loss of balloon pressure and aspiration of ambient air through a leak in a defective or damaged tonometry catheter can lead to erroneously low PrCO 2 values 11 . For accurate and reliable PrCO 2 measurements by the TONOCAP®, not only a closed TONOCAP ®catheter pathway but also a constant relationship between catheter deadspace volume and sampling balloon volume is essential 12 . Therefore we investigated the influence of different impediments to the filling of the tonometer sampling balloon on measurement of luminal PrCO 2 by the TONOCAP®.
MATERIALS AND METHODS
The TONOCAP® device (Tonometrics, Helsinki, Finland) is an infrared based CO 2 analyser equipped with a pump to inflate the balloon of an attached tonometry catheter with air and to aspirate a sample after a chosen equilibration time.
The first portion of the gas sample is discarded to avoid admixture of catheter deadspace air to the balloon gas portion. After analysing, the gas portion is recycled into the balloon to decrease equilibration times and to avoid CO 2 depletion in the gastric mucosa.
After starting the TONOCAP® device, a selfcheck is automatically performed. Before measuring, an initialization procedure is performed to confirm proper connection and function of the tonometry catheter. Measurement cycles are performed automatically at a pre-set rate (10, 15, 20 minutes) or can be started manually after a minimal equilibration period. An internal pressure sensor measures the pressure of the sampling balloon prior to gas aspiration and the pressure in the analyser after aspiration of the sampling volume. Simultaneously, CO 2 concentration is measured within the analyser chamber. The PCO 2 value in the balloon is given by the following equation: PCO 2 balloon =P balloon /P analyser xCO 2 % in the analyser xP ambient .
Apart from analysing PCO 2 from the sampling balloon, the TONOCAP® measures PCO 2 from an additional sampling line, usually connected to the tracheal tube for measuring end-tidal CO 2 . This curve is displayed and breathing frequency calculated from it. Intramucosal pH can be calculated by providing the TONOCAP® with values from blood gas analysis.
Two catheter-related alarms are provided by the TONOCAP® device: "catheter pressure<minimum" (at catheter pressure less than 10 mmHg+ambient pressure) and "catheter pressure low" (catheter pressure less than 64% of the filling pressure) 13 .
In an in vitro setup, an 8F tonometry catheter (TRIP Tonometry Catheter 8F, Datex Ohmeda, Helsinki, Finland) consisting of a sampling line and a sampling balloon was placed with the sampling balloon in a 50 ml container, continuously flushed with oxycarbon (5% CO 2 in O 2 ) 2 l/min. The sampling line was connected to the TONOCAP® PrCO 2 port with a three-way stopcock interposed ( Figure 1 ). For determination of balloon pressures, the side-port of the interposed stopcock was attached to an invasive blood pressure transducer connected to a pressure monitor. The PETCO 2 port of the TONOCAP ® was used to monitor PCO 2 within the container (PcCO 2 ) surrounding the sampling balloon by means of an additional sampling line placed with its tip at level of the sampling balloon.
The following experiments were performed: A) control measurements without modifications to obtain reference values for the experimental set-up, B) measurements with increased catheter deadspace by interposition of an additional 1 m long tubing extension (7 ml internal volume) (B Braun, Melsungen, Germany) between tonometry catheter sampling line and three-way stopcock, C) restriction of balloon expansion by placing the sampling balloon into a 3 ml syringe (B Braun, Melsungen, Germany) the barrel of the distal syringe removed to allow balloon expansion into both axial directions, D) restriction of balloon filling by cross-clamping the sampling balloon in the middle by a protected surgical clamp, thereby simulating balloon kinking.
In each experiment, initialization of the TONO-CAP® was performed with an empty sampling balloon. First measurement of PrCO 2 , t 0 , was automatically started by the TONOCAP®, followed by measurements repeated every 10 minutes for two hours, i.e. until t 120 . Balloon filling pressures (mmHg) were recorded after each measurement. PcCO 2 values were continuously monitored. Catheter pressure alarms displayed by the TONOCAP® were noted and then "suppressed". Each experiment was done four times using two 8F tonometry catheters on two models of TONOCAP® recently checked by the manufacturer and both calibrated prior to testing. Measurements were performed at room temperatures of 22 to 23°C and constant ambient pressure.
Statistical Analyses
For every measurement the mean±SD for PcCO 2 , PrCO 2 , difference between PcCO 2 and PrCO 2 (Pc-rCO 2 ) and balloon filling pressures were calculated. Statistical testing was done for comparing Pc-rCO 2 values and balloon filling pressures between experiments B-D and reference values (A), between TONOCAP® devices and between tonometry catheters by ANOVA using Scheffe's correction for multiple testing. Statistical significance was set at P<0.05.
RESULTS
PrCO 2 reached steady state values in the control set-up (A) after two cycles. The difference between PcCO 2 and PrCO 2 amounted to 0.16±0.22%, but attained no statistical significance (P=0.34). Mean balloon filling pressure was 107.0±3.6 mmHg.
Increasing the deadspace in the sampling line (B) resulted in significantly lower PrCO 2 values with a mean Pc-rCO 2 of 3.2±0.57% (P<0.0001). Balloon filling pressures were 72.5±3.6 mmHg. In eight of the 52 measurements, "catheter pressure low" or "check catheter" alarms were provided.
Restriction of balloon expansion (C) caused a
Pc-rCO 2 of 1.17±0.36% (P<0.0001) and increased balloon filling pressures to 138.5±2.3 mmHg (P<0.0001). Surprisingly, the "catheter pressure low" alarm was displayed seven times.
With restriction of balloon filling by kinking the sampling balloon, the Pc-rCO 2 increased to 3.87± 0.29% (P<0.0001) whereas balloon filling pressures decreased to 78.9±2.8 mmHg (P<0.0001) ( Figure  2D ). "Catheter pressure low" alarm was displayed twice.
No differences regarding the Pc-rCO 2 , balloon fill- ing pressures and catheter alarms were found between the two TONOCAP ® devices and the two tonometry catheters.
DISCUSSION
We studied the effects of sampling line deadspace and sampling balloon filling on measurement of PrCO 2 by the TONOCAP®. The main finding was that increasing the sampling line deadspace in relation to the balloon volume impairs the accuracy of in vitro performance of air tonometry using the TONOCAP® device without persistently displaying a catheter alarm.
The introduction of automated air tonometry has not only facilitated the assessment of PrCO 2 in the clinical setting, but also offset problems inherent in the methodology of saline tonometry, in particular saline buffer substances, equilibration duration dependence, CO 2 loss during transportation, temperature dependence and underestimation of PCO 2 in saline by different blood gas analysers, which adversely affect the accuracy and reliability of PrCO 2 assessment 5, [14] [15] [16] . Furthermore, automated cyclic determination of PrCO 2 by the TONOCAP ® provides a promising tool for almost continuous monitoring of splanchnic perfusion without the need of a blood gas analyser.
As demonstrated by our findings, impairment of the relation between dead space volume and balloon filling volume seems to affect air tonometric assessment of balloon PCO 2 . It is beyond our technical knowledge of the TONOCAP® device to explain all findings, but our suggestions are as follows. Generally, increased deadspace volume to balloon volume ratio leads to admixture of sampling line gas to the analysed gas probe with consecutive dilution of the balloon CO 2 within the infrared analysing chamber and therefore to lower PrCO 2 values. This is clearly demonstrated by experiment B.
The minor balloon expansion restriction in experiment C resulted in higher balloon pressures by the reduced balloon compliance. Sampling line and sampling syringe within the TONOCAP® may have become more distended due to the elevated catheter pressure, resulting in both increased deadspace volume and reduced balloon volume.
Major restriction of balloon filling in experiment D resulted in surprisingly low balloon pressures. A systematic error or a technical problem can be excluded because the experiments revealed uniform results (SD <5%) and were performed on different days with different catheters and TONOCAP® devices also used for the other three experiments.
The low pressures found in this experiment are probably the result of the initialization procedure, detecting the high resistance and consequently reducing the volume inflated, leading to an increased deadspace volume to balloon volume ratio and low PrCO 2 values.
Although the TONOCAP® has integrated catheter alarms, responding to high pressure and falls of balloon pressure by air leaks, the alarms in the simulated in vitro situations were not adequate and failed after first "alarm suppression" by the investigator. Although alarms should not be "deleted" but acted upon, it is usual clinical practice to repeat the measurement and if the problems do not recur, the machine is believed to work well.
Although the gross impediments applied to balloon filling and deadspace are unlikely to occur in the clinical setting, our findings have several implications of which the clinician should be aware.
Firstly, additional tube extension should not be used for tonometry catheters to increase the distance between patient and TONOCAP®, an important issue in rectosigmoid tonometry.
Secondly, the sampling balloon should not be placed and maintained in a volume restriction guiding device. Additional measuring probes should not be attached to the balloon by circular tapes 17 . One must be careful not to place the sampling balloon in a narrow hollow organ or body space for PrCO 2 measurement, in particular when using tonometry in small children.
Thirdly, any catheter alarms should be carefully checked for air leak and proper connection of catheter and device. Correct catheter placement should be verified and any balloon filling restriction by kinking of the balloon or kinking of the catheter between TONOCAP® and patient excluded. Afterwards, the TONOCAP® device should be switched off and re-initialized.
Fourthly, the device would benefit from additional monitoring and from a display of catheter pressure and gas volume aspirated. In addition to the catheter alarms provided, this would enable the user to better recognise air leakage with reduced total sampling volume.
Fifthly, according to the manufacturer's information, tonometer catheters (5F) with smaller balloon volumes, as used in neonatology, should not be connected to a TONOCAP® 18 . The fact that a certain amount of deadspace volume from the sampling line has to be discharged before the balloon gas volume is analysed does not allow design of smaller tonometry balloons for use in small children. Newer approaches that avoid the need for aspiration and re-inflating the gas probe through the same tube include the cycling double-lumen tonometry catheter reported by Frojse and the fibreoptic tonometry catheter presented by Knichwitz 19, 20 .
In conclusion, increased catheter deadspace in relation to the balloon volume can impair the accuracy of PrCO 2 measurement by the TONO-CAP®. Additional displays indicating catheter pressure and gas volume sampled would be more helpful to detect catheter-and balloon-related problems to improve accuracy of air tonometry.
